Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
Provided By GlobeNewswire
Last update: May 9, 2024
Continued Enrollment in Global Phase 3 CoMpass Trial in Small Choroidal Melanoma and Indeterminate Lesions
Ongoing Phase 1 Trial in Bladder Cancer Enrolling; Early Data Expected Mid-2024
Read more at globenewswire.com
